Jane Street
TXMD icon

Jane Street’s TherapeuticsMD TXMD Stock Holding History

Jane Street’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-292
Closed -$5K – 11042
2021
Q4 		$5K Sell
292
-70
-19% -$2.1K ﹤0.01% 9949
2021
Q3 		$13K Sell
362
-414
-53% -$18.4K ﹤0.01% 9792
2021
Q2 		$46K Sell
776
-1,226
-61% -$74.3K ﹤0.01% 9524
2021
Q1 		$134K Buy
2,002
+1,700
+563% +$133K ﹤0.01% 8513
2020
Q4 		$18K Sell
302
-70
-19% -$4.78K ﹤0.01% 7373
2020
Q3 		$29K Buy
+372
New +$29.7K ﹤0.01% 7001
2019
Q1 		– Sell
-548
Closed -$104K – 5657
2018
Q4 		$104K Hold
548
– – ﹤0.01% 4619
2018
Q3 		$180K Buy
+548
New +$168K ﹤0.01% 4729

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's TXMD Position: Q2 2022 in Review

Jane Street sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 382 shares — an estimated $7K sold.

Jane Street first reported a position in TXMD in Q1 2014 and held it in 20 quarters. The position peaked at $526K in Q4 2017. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Jane Street reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 382 TherapeuticsMD shares in Q2 2022, an estimated $7K.
  • Jane Street first reported a position in TherapeuticsMD in Q1 2014 and held it in 20 quarters.
  • Jane Street's TherapeuticsMD position peaked at $526K in Q4 2017.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.